Improving Treatment and Outcomes for Melioidosis in Children, Northern Cambodia, 2009-2018

Area of Science:

• Pediatric infectious diseases
• Clinical microbiology
• Epidemiology of tropical diseases

Background:

• Melioidosis, a serious bacterial infection caused by Burkholderia pseudomallei, poses a significant threat in tropical regions.
• Understanding the clinical spectrum and outcomes of melioidosis in children is crucial for effective management.

Purpose of the Study:

• To analyze trends in manifestations, treatment, and outcomes of pediatric melioidosis.
• To identify risk factors for mortality in children with melioidosis.
• To evaluate the effectiveness of oral antimicrobial therapy in a subset of patients.

Main Methods:

• Retrospective analysis of 355 children with culture-confirmed melioidosis.
• Data collected over a 10-year period at a pediatric hospital in northern Cambodia.
• Assessment of clinical presentation, treatment regimens, and patient outcomes.

Main Results:

• Bacteremia and pneumonia were identified as significant risk factors for mortality.
• A total of 39 children achieved recovery solely through oral antimicrobial drug treatment.
• The study highlights variations in disease presentation and treatment response.

Conclusions:

• Melioidosis in children requires prompt recognition and management, particularly in endemic areas.
• Early identification of risk factors like bacteremia and pneumonia can guide treatment intensity.
• Oral antimicrobial therapy may be a viable option for select pediatric melioidosis cases, warranting further investigation.